Hess Paul R, Barnes Carie, Woolard Matthew D, Johnson Michael D L, Cullen John M, Collins Edward J, Frelinger Jeffrey A
Department of Microbiology and Immunology, Universaity of North Carolina, Chapel Hill, NC, USA.
Blood. 2007 Apr 15;109(8):3300-7. doi: 10.1182/blood-2006-06-028001. Epub 2006 Dec 19.
CD8+ cytotoxic T lymphocytes (CTLs) are important effector cells responsible for tissue destruction in several autoimmune and allograft-related diseases. To discover if pathogenic T cells could be selectively deleted, we investigated the ability of a toxin coupled to major histocompatibility complex (MHC) class I tetramers to kill antigen-specific CD8+ T cells. H2-D(b) tetramers were assembled using streptavidin conjugated to the ribosome-inactivating protein (RIP) saporin (SAP). These tetramers inhibited ribosome activity in vitro, retained the T-cell receptor (TCR)-binding specificity of their nontoxic counterparts, and were internalized by 100% of target cells, leading to cell death in 72 hours. Cytotoxicity was dependent on the tetramer dose and avidity for the T cell. A single injection of the SAP-coupled tetramer eliminated more than 75% of cognate, but not control, T cells. This work demonstrates the therapeutic potential of cytotoxic tetramers to selectively eradicate pathogenic clonotypes while leaving overall T-cell immunity intact.
CD8 + 细胞毒性T淋巴细胞(CTLs)是在多种自身免疫性疾病和同种异体移植相关疾病中负责组织破坏的重要效应细胞。为了探究致病性T细胞是否可以被选择性清除,我们研究了一种与主要组织相容性复合体(MHC)I类四聚体偶联的毒素杀伤抗原特异性CD8 + T细胞的能力。使用与核糖体失活蛋白(RIP)皂草素(SAP)偶联的链霉亲和素组装H2-D(b)四聚体。这些四聚体在体外抑制核糖体活性,保留其无毒对应物的T细胞受体(TCR)结合特异性,并被100%的靶细胞内化,导致72小时内细胞死亡。细胞毒性取决于四聚体剂量和对T细胞的亲和力。单次注射SAP偶联的四聚体可清除超过75%的同源T细胞,但不清除对照T细胞。这项研究证明了细胞毒性四聚体在选择性根除致病性克隆型同时保持整体T细胞免疫完整的治疗潜力。